Welcome!

News Feed Item

Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast - Worldwide

NEW YORK, Feb. 13, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast - Worldwide
http://www.reportlinker.com/p02016014/Blood-Glucose-Device-SMBG-Test-Strips-Lancet-Meter-Market--Forecast---Worldwide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Blood glucose monitoring devices market is very lucrative business with enormous future potential. Self-monitoring blood glucose market is primarily dependent on number of diabetic patients. So with the growth in diabetic patients blood glucose monitoring devices market is set to grow many folds. By the end of 2013 there was 382 Million people suffering from diabetes and this figure is expect to rise further to 592 Million by 2035.

For the year 2013 Self-monitoring blood glucose (SMBG) users has grown more than 50% from the number of users in 2007. China has the highest number of self-monitoring blood glucose device users but United States has highest number of test strips market share. Although self-monitoring blood glucose devices market is expected to grow with single digit CAGR, but its market is in double digit Billion US$. United States controls the highest market share in the self-monitoring blood glucose (SMBG) market worldwide. 4 companies Roche Diagnostic, LifeScan Inc., Bayer HealthCare and Abbott Laboratories together controls nearly 50% market share of self-monitoring blood glucose devices.

Renub Research study titled "Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast - Worldwide" analyzes the worldwide markets for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This report studies separate comprehensive analytics for the 15 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2014 through 2020. A six year historic analysis is also provided for these markets.

This 265 page report with 257 Figures and 12 Tables provides a complete analysis of top 15 countries of worldwide self-monitoring blood glucose (SMBG) market. All the 15 countries in the report have been studied from 7 viewpoints.

• Countries Diabetes Population Scenario and Future Forecast
• Countries Type 1 and Type 2 Diabetes Scenario and Future Forecast
• Countries Self-Monitoring Blood Glucose (SMBG) devices Users and Future Forecast
• Countries Self-Monitoring Blood Glucose devices (SMBG) Market and Future Forecast
• Countries Blood Glucose Test Strips Market and Future Forecast
• Countries Blood Glucose Lancet Market and Future Forecast
• Countries Blood Glucose Meter and Future Forecast

Top 15 Countries is Covered in this Report

1. United States
2. United Kingdom
3. Germany
4. Spain
5. Italy
6. Netherlands
7. Norway
8. Sweden
9. Switzerland
10. Brazil
11. Russia
12. India
13. China
14. Australia
15. Kuwait

4 Companies Revenue (Sales) from self-monitoring blood glucose (SMBG) devices have been analyzed in this report.

• Roche Diagnostic
• LifeScan Inc.,
• Bayer HealthCare
• Abbott Laboratories

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

1. Executive Summary

2. Worldwide Self-Monitoring of Blood Glucose (SMBG) Users and Forecast
2.1 Worldwide Self-Monitoring of Blood Glucose (SMBG) Users Share and Forecast

3. Worldwide Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
3.1 Worldwide Blood Glucose Test Strips Market and Forecast
3.2 Worldwide Blood Glucose Lancet Market and Forecast
3.3 Worldwide Blood Glucose Meter Market and Forecast

4. Worldwide Self-Monitoring of Blood Glucose (SMBG) Market Share and Forecast
4.1 Worldwide Blood Glucose Test Strips Market Share and Forecast
4.2 Worldwide Blood Glucose Lancet Market Share and Forecast
4.3 Worldwide Blood Glucose Meter Market Share and Forecast
4.4 Worldwide - Key Players Self-Monitoring Blood Glucose (SMBG) Revenue Share Analysis

5. United States
5.1 United States Diabetes Population and Forecast
5.1.1 United States Type 1 Diabetes Population and Forecast
5.1.2 United States Type 2 Diabetes Population and Forecast

5.2 United States Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

5.3 United States Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
5.3.1 United States Blood Glucose Test Strips Market and Forecast
5.3.2 United States Blood Glucose Lancet Market and Forecast
5.3.3 United States Blood Glucose Meter Market and Forecast

5.4 Reimbursement in United States

6. United Kingdom
6.1 United Kingdom Diabetes Population and Forecast
6.1.1 United Kingdom Type 1 Diabetes Population and Forecast
6.1.2 United Kingdom Type 2 Diabetes Population and Forecast

6.2 United Kingdom Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

6.3 United Kingdom Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
6.3.1 United Kingdom Blood Glucose Test Strips Market and Forecast
6.3.2 United Kingdom Blood Glucose Lancet Market and Forecast
6.3.3 United Kingdom Blood Glucose Meter Market and Forecast

6.4 Reimbursement in United Kingdom

7. Germany
7.1 Germany Diabetes Population and Forecast
7.1.1 Germany Type 1 Diabetes Population and Forecast
7.1.2 Germany Type 2 Diabetes Population and Forecast

7.2 Germany Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

7.3 Germany Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
7.3.1 Germany Blood Glucose Test Strips Market and Forecast
7.3.2 Germany Blood Glucose Lancet Market and Forecast
7.3.3 Germany Blood Glucose Meter Market and Forecast

7.4 Reimbursement in Germany

8. Spain
8.1 Spain Diabetes Population and Forecast
8.1.1 Spain Type 1 Diabetes Population and Forecast
8.1.2 Spain Type 2 Diabetes Population and Forecast

8.2 Spain Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

8.3 Spain Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
8.3.1 Spain Blood Glucose Test Strips Market and Forecast
8.3.2 Spain Blood Glucose Lancet Market and Forecast
8.3.3 Spain Blood Glucose Meter Market and Forecast

8.4 Reimbursement in Spain

9. Italy
9.1 Italy Diabetes Population and Forecast
9.1.1 Italy Type 1 Diabetes Population and Forecast
9.1.2 Italy Type 2 Diabetes Population and Forecast

9.2 Italy Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

9.3 Italy Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
9.3.1 Italy Blood Glucose Test Strips Market and Forecast
9.3.2 Italy Blood Glucose Lancet Market and Forecast
9.3.3 Italy Blood Glucose Meter Market and Forecast

9.4 Reimbursement in Italy

10. Netherlands
10.1 Netherlands Diabetes Population and Forecast
10.1.1 Netherlands Type 1 Diabetes Population and Forecast
10.1.2 Netherlands Type 2 Diabetes Population and Forecast

10.2 Netherlands Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

10.3 Netherlands Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
10.3.1 Netherlands Blood Glucose Test Strips Market and Forecast
10.3.2 Netherlands Blood Glucose Lancet Market and Forecast
10.3.3 Netherlands Blood Glucose Meter Market and Forecast

10.4 Reimbursement in Netherlands

11. Norway
11.1 Norway Diabetes Population and Forecast
11.1.1 Norway Type 1 Diabetes Population and Forecast
11.1.2 Norway Type 2 Diabetes Population and Forecast

11.2 Norway Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

11.3 Norway Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
11.3.1 Norway Blood Glucose Test Strips Market and Forecast
11.3.2 Norway Blood Glucose Lancet Market and Forecast
11.3.3 Norway Blood Glucose Meter Market and Forecast

11.4 Reimbursement in Norway

12. Sweden
12.1 Sweden Diabetes Population and Forecast
12.1.1 Sweden Type 1 Diabetes Population and Forecast
12.1.2 Sweden Type 2 Diabetes Population and Forecast

12.2 Sweden Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

12.3 Sweden Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
12.3.1 Sweden Blood Glucose Test Strips Market and Forecast
12.3.2 Sweden Blood Glucose Lancet Market and Forecast
12.3.3 Sweden Blood Glucose Meter Market and Forecast

12.4 Reimbursement in Sweden

13. Switzerland
13.1 Switzerland Diabetes Population and Forecast
13.1.1 Switzerland Type 1 Diabetes Population and Forecast
13.1.2 Switzerland Type 2 Diabetes Population and Forecast

13.2 Switzerland Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

13.3 Switzerland Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
13.3.1 Switzerland Blood Glucose Test Strips Market and Forecast
13.3.2 Switzerland Blood Glucose Lancet Market and Forecast
13.3.3 Switzerland Blood Glucose Meter Market and Forecast

13.4 Reimbursement in Switzerland

14. Russia
14.1 Russia Diabetes Population and Forecast
14.1.1 Russia Type 1 Diabetes Population and Forecast
14.1.2 Russia Type 2 Diabetes Population and Forecast

14.2 Russia Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

14.3 Russia Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
14.3.1 Russia Blood Glucose Test Strips Market and Forecast
14.3.2 Russia Blood Glucose Lancet Market and Forecast
14.3.3 Russia Blood Glucose Meter Market and Forecast

14.4 Reimbursement in Russia

15. Brazil
15.1 Brazil Diabetes Population and Forecast

15.2 Brazil Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

15.3 Brazil Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
15.3.1 Brazil Blood Glucose Test Strips Market and Forecast
15.3.2 Brazil Blood Glucose Lancet Market and Forecast
15.3.3 Brazil Blood Glucose Meter Market and Forecast

15.4 Reimbursement in Brazil

16. India
16.1 India Diabetes Population and Forecast
16.1.1 India Type 1 Diabetes Population and Forecast
16.1.2 India Type 2 Diabetes Population and Forecast

16.2 India Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

16.3 India Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
16.3.1 India Blood Glucose Test Strips Market and Forecast
16.3.2 India Blood Glucose Lancet Market and Forecast
16.3.3 India Blood Glucose Meter Market and Forecast

17. China
17.1 China Diabetes Population and Forecast
17.1.1 China Type 1 Diabetes Population and Forecast
17.1.2 China Type 2 Diabetes Population and Forecast

17.2 China Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

17.3 China Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
17.3.1 China Blood Glucose Test Strips Market and Forecast
17.3.2 China Blood Glucose Lancet Market and Forecast
17.3.3 China Blood Glucose Meter Market and Forecast

18. Australia
18.1 Australia Diabetes Population and Forecast
18.1.1 Australia Type 1 Diabetes Population and Forecast
18.1.2 Australia Type 2 Diabetes Population and Forecast

18.2 Australia Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

18.3 Australia Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
18.3.1 Australia Blood Glucose Test Strips Market and Forecast
18.3.2 Australia Blood Glucose Lancet Market and Forecast
18.3.3 Australia Blood Glucose Meter Market and Forecast

18.4 Reimbursement in Australia

19. Kuwait
19.1 Kuwait Diabetes Population and Forecast
19.1.1 Kuwait Type 1 Diabetes Population and Forecast
19.1.2 Kuwait Type 2 Diabetes Population and Forecast

19.2 Kuwait Self-Monitoring of Blood Glucose (SMBG) Users and Forecast

19.3 Kuwait Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
19.3.1 Kuwait Blood Glucose Test Strips Market and Forecast
19.3.2 Kuwait Blood Glucose Lancet Market and Forecast
19.3.3 Kuwait Blood Glucose Meter Market and Forecast

20. SMBG Market Growth Drivers
20.1 Increased Government Programs for Diabetes Care Awareness
20.2 Raising Government funding for Diabetes Management
20.3 Growing Expenditures on Diabetes Management & Worldwide per Capita Healthcare Expending

21. SMBG Market Challenges
21.1 Blood Glucose Meter Accuracy Problem Acknowledged by FDA, Industry & Clinicians
21.2 Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies

22. Key Players Analysis
22.1 Roche Diagnostic
22.1.1 Roche Diagnostic SMBG Revenue & Forecast

22.2 LifeScan Inc.
22.2.1 LifeScan SMBG Revenue & Forecast

22.3 Bayer HealthCare
22.3.1 Bayer HealthCare SMBG Revenue & Forecast

22.4 Abbott Laboratories
22.4.1 Abbott Laboratories SMBG Revenue & Forecast

List of Tables

Table 2 1: Worldwide: Self-Monitoring of Blood Glucose (SMBG) Users Share (Percent), 2007 – 2013
Table 2 2: Worldwide: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users Share (Percent), 2014 – 2020

Table 4 1: Worldwide: Self-Monitoring of Blood Glucose (SMBG) Market Share (Percent), 2007 – 2013
Table 4 2: Worldwide: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market Share (Percent), 2014 – 2020
Table 4 3: Worldwide: Blood Glucose Test Strips Market Share (Percent), 2007 – 2013
Table 4 4: Worldwide: Forecast for Blood Glucose Test Strips Market Share (Percent), 2014 – 2020
Table 4 5: Worldwide: Blood Glucose Lancet Market Share (Percent), 2007 – 2013
Table 4 6: Worldwide: Forecast for Blood Glucose Lancet Market Share (Percent), 2014 – 2020
Table 4 7: Worldwide: Blood Glucose Meter Market Share (Percent), 2007 – 2013
Table 4 8: Worldwide: Forecast for Blood Glucose Meter Market Share (Percent), 2014 – 2020

Table 20 1: United States: Estimated Spending for Pre-diabetes and Diabetes by the Federal Government and States (US$ Billion), 2011 – 2020
Table 20 2: Worldwide: Per Capita Healthcare Spending (US$), 2005 – 2012

List of Figures

Figure 2 1: Worldwide: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 2 2: Worldwide: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020

Figure 3 1: Worldwide: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 3 2: Worldwide: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 3 3: Worldwide: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 3 4: Worldwide: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 3 5: Worldwide: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 3 6: Worldwide: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 3 7: Worldwide: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 3 8: Worldwide: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 4 1: Worldwide: Key Players SMBG Share (Percent), 2007 – 2008 & 2010 – 2013
Figure 4 2: Worldwide: Forecast for Key Players SMBG Share (Percent), 2014 – 2020

Figure 5 1: United States: Diabetes Population (Thousand), 2007 – 2013
Figure 5 2: United States: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 5 3: United States: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 5 4: United States: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 5 5: United States: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 5 6: United States: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 5 7: United States: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 5 8: United States: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 5 9: United States: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 5 10: United States: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 5 11: United States: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 5 12: United States: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 5 13: United States: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 5 14: United States: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 5 15: United States: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 5 16: United States: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 6 1: United Kingdom: Diabetes Population (Thousand), 2007 – 2013
Figure 6 2: United Kingdom: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 6 3: United Kingdom: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 6 4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 6 5: United Kingdom: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 6 6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 6 7: United Kingdom: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 6 8: United Kingdom: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 6 9: United Kingdom: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 6 10: United Kingdom: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 6 11: United Kingdom: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 6 12: United Kingdom: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 6 13: United Kingdom: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 6 14: United Kingdom: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 6 15: United Kingdom: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 6 16: United Kingdom: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 7 1: Germany: Diabetes Population (Thousand), 2007 – 2013
Figure 7 2: Germany: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 7 3: Germany: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 7 4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 7 5: Germany: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 7 6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 7 7: Germany: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand) 2007 – 2013
Figure 7 8: Germany: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand) 2014 – 2020
Figure 7 9: Germany: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 7 10: Germany: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 7 11: Germany: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 7 12: Germany: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 7 13: Germany: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 7 14: Germany: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 7 15: Germany: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 7 16: Germany: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 8 1: Spain: Diabetes Population (Thousand), 2007 – 2013
Figure 8 2: Spain: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 8 3: Spain: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 8 4: Spain: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 8 5: Spain: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 8 6: Spain: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 8 7: Spain: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 8 8: Spain: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 8 9: Spain: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 8 10: Spain: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 8 11: Spain: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 8 12: Spain: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 8 13: Spain: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 8 14: Spain: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 8 15: Spain: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 8 16: Spain: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 9 1: Italy: Diabetes Population (Thousand), 2007 – 2013
Figure 9 2: Italy: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 9 3: Italy: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 9 4: Italy: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 9 5: Italy: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 9 6: Italy: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 9 7: Italy: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 9 8: Italy: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 9 9: Italy: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 9 10: Italy: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 9 11: Italy: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 9 12: Italy: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 9 13: Italy: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 9 14: Italy: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 9 15: Italy: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 9 16: Italy: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 10 1: Netherlands: Diabetes Population (Thousand), 2007 – 2013
Figure 10 2: Netherlands: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 10 3: Netherlands: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 10 4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 10 5: Netherlands: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 10 6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 10 7: Netherlands: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 10 8: Netherlands: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 10 9: Netherlands: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 10 10: Netherlands: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 10 11: Netherlands: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 10 12: Netherlands: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 10 13: Netherlands: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 10 14: Netherlands: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 10 15: Netherlands: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 10 16: Netherlands: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 11 1: Norway: Diabetes Population (Thousand), 2007 – 2013
Figure 11 2: Norway: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 11 3: Norway: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 11 4: Norway: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 11 5: Norway: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 11 6: Norway: Forecast for Type 2 Diabetes Users (Thousand), 2014 – 2020
Figure 11 7: Norway: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 11 8: Norway: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 11 9: Norway: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 11 10: Norway: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 11 11: Norway: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 11 12: Norway: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 11 13: Norway: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 11 14: Norway: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 11 15: Norway: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 11 16: Norway: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 12 1: Sweden: Diabetes Population (Thousand), 2007 – 2013
Figure 12 2: Sweden: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 12 3: Sweden: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 12 4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 12 5: Sweden: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 12 6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 12 7: Sweden: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 12 8: Sweden: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 12 9: Sweden: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 12 10: Sweden: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 12 11: Sweden: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 12 12: Sweden: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 12 13: Sweden: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 12 14: Sweden: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 12 15: Sweden: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 12 16: Sweden: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 13 1: Switzerland: Diabetes Population (Thousand), 2007 – 2013
Figure 13 2: Switzerland: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 13 3: Switzerland: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 13 4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 13 5: Switzerland: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 13 6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 13 7: Switzerland: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 13 8: Switzerland: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 13 9: Switzerland: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 13 10: Switzerland: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 13 11: Switzerland: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 13 12: Switzerland: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 13 13: Switzerland: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 13 14: Switzerland: Forecast Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 13 15: Switzerland: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 13 16: Switzerland: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 14 1: Russia: Diabetes Population (Thousand), 2007 – 2013
Figure 14 2: Russia: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 14 3: Russia: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 14 4: Russia: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 14 5: Russia: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 14 6: Russia: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 14 7: Russia: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 14 8: Russia: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 14 9: Russia: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 14 10: Russia: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 14 11: Russia: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 14 12: Russia: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 14 13: Russia: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 14 14: Russia: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 14 15: Russia: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 14 16: Russia: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 15 1: Brazil: Diabetes Population (Thousand), 2007 – 2013
Figure 15 2: Brazil: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 15 3: Brazil: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 15 4: Brazil: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 15 5: Brazil: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 15 6: Brazil: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 15 7: Brazil: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 15 8: Brazil: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 15 9: Brazil: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 15 10: Brazil: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 15 11: Brazil: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 15 12: Brazil: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 16 1: India: Diabetes Population (Thousand), 2007 – 2013
Figure 16 2: India: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 16 3: India: Type 1 Diabetes Population (Thousand), 2008-2013
Figure 16 4: India: Forecast for Type 1 Diabetes Population (Thousand), 2014-2020
Figure 16 5: India: Type 2 Diabetes Population (Thousand), 2008-2013
Figure 16 6: India: Forecast for Type 2 Diabetes Population (Thousand), 2014-2020
Figure 16 7: India: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 16 8: India: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 16 9: India: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 16 10: India: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 16 11: India: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 16 12: India: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 16 13: India: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 16 14: India: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 16 15: India: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 16 16: India: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 17 1: China: Diabetes Population (Thousand), 2007 – 2013
Figure 17 2: China: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 17 3: China: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 17 4: China: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 17 5: China: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 17 6: China: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 17 7: China: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 17 8: China: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 17 9: China: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 17 10: China: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 17 11: China: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 17 12: China: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 17 13: China: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 17 14: China: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 17 15: China: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 17 16: China: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 18 1: Australia: Diabetes Population (Thousand), 2007 – 2013
Figure 18 2: Australia: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 18 3: Australia: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 18 4: Australia: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 18 5: Australia: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 18 6: Australia: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 18 7: Australia: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 18 8: Australia: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 18 9: Australia: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 18 10: Australia: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 18 11: Australia: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 18 12: Australia: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 18 13: Australia: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 18 14: Australia: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 18 15: Australia: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 18 16: Australia: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 19 1: Kuwait: Diabetes Population (Thousand), 2007 – 2013
Figure 19 2: Kuwait: Forecast for Diabetes Population (Thousand), 2014 – 2020
Figure 19 3: Kuwait: Type 1 Diabetes Population (Thousand), 2007 – 2013
Figure 19 4: Kuwait: Forecast for Type 1 Diabetes Population (Thousand), 2014 – 2020
Figure 19 5: Kuwait: Type 2 Diabetes Population (Thousand), 2007 – 2013
Figure 19 6: Kuwait: Forecast for Type 2 Diabetes Population (Thousand), 2014 – 2020
Figure 19 7: Kuwait: Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2007 – 2013
Figure 19 8: Kuwait: Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2014 – 2020
Figure 19 9: Kuwait: Self-Monitoring Blood Glucose (SMBG) Market (Million US$), 2007 – 2013
Figure 19 10: Kuwait: Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2014 – 2020
Figure 19 11: Kuwait: Blood Glucose Test Strips Market (Million US$), 2007 – 2013
Figure 19 12: Kuwait: Forecast for Blood Glucose Test Strips Market (Million US$), 2014 – 2020
Figure 19 13: Kuwait: Blood Glucose Lancet Market (Million US$), 2007 – 2013
Figure 19 14: Kuwait: Forecast for Blood Glucose Lancet Market (Million US$), 2014 – 2020
Figure 19 15: Kuwait: Blood Glucose Meter Market (Million US$), 2007 – 2013
Figure 19 16: Kuwait: Forecast for Blood Glucose Meter Market (Million US$), 2014 – 2020

Figure 20 1: Worldwide: Healthcare Spending on Diabetes (Billion US$), 2010 & 2030

Figure 22 1: Worldwide: Roche Diagnostic SMBG Revenue (Million US$), 2007 – 2013
Figure 22 2: Worldwide: Forecast for Roche Diagnostic SMBG Revenue (Million US$), 2014 – 2020
Figure 22 3: Worldwide: LifeScan SMBG Revenue (Million US$), 2007 – 2008 & 2010 – 2013
Figure 22 4: Worldwide: Forecast for LifeScan SMBG Revenue (Million US$), 2014 – 2020
Figure 22 5: Worldwide: Bayer Healthcare SMBG Revenue (Million US$), 2007 – 2013
Figure 22 6: Worldwide: Forecast for Bayer Healthcare SMBG Revenue (Million US$), 2014 – 2020
Figure 22 7: Worldwide: Abbott Laboratories SMBG Revenue (Million US$), 2007 – 2013
Figure 22 8: Worldwide: Forecast for Abbott Laboratories SMBG Revenue (Million US$), 2014 – 2020

To order this report: Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast - Worldwide
http://www.reportlinker.com/p02016014/Blood-Glucose-Device-SMBG-Test-Strips-Lancet-Meter-Market--Forecast---Worldwide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
Both SaaS vendors and SaaS buyers are going “all-in” to hyperscale IaaS platforms such as AWS, which is disrupting the SaaS value proposition. Why should the enterprise SaaS consumer pay for the SaaS service if their data is resident in adjacent AWS S3 buckets? If both SaaS sellers and buyers are using the same cloud tools, automation and pay-per-transaction model offered by IaaS platforms, then why not host the “shrink-wrapped” software in the customers’ cloud? Further, serverless computing, cl...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
The taxi industry never saw Uber coming. Startups are a threat to incumbents like never before, and a major enabler for startups is that they are instantly “cloud ready.” If innovation moves at the pace of IT, then your company is in trouble. Why? Because your data center will not keep up with frenetic pace AWS, Microsoft and Google are rolling out new capabilities. In his session at 20th Cloud Expo, Don Browning, VP of Cloud Architecture at Turner, posited that disruption is inevitable for comp...
"When we talk about cloud without compromise what we're talking about is that when people think about 'I need the flexibility of the cloud' - it's the ability to create applications and run them in a cloud environment that's far more flexible,” explained Matthew Finnie, CTO of Interoute, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
No hype cycles or predictions of zillions of things here. IoT is big. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, Associate Partner at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He discussed the evaluation of communication standards and IoT messaging protocols, data analytics considerations, edge-to-cloud tec...
IoT solutions exploit operational data generated by Internet-connected smart “things” for the purpose of gaining operational insight and producing “better outcomes” (for example, create new business models, eliminate unscheduled maintenance, etc.). The explosive proliferation of IoT solutions will result in an exponential growth in the volume of IoT data, precipitating significant Information Governance issues: who owns the IoT data, what are the rights/duties of IoT solutions adopters towards t...
It is ironic, but perhaps not unexpected, that many organizations who want the benefits of using an Agile approach to deliver software use a waterfall approach to adopting Agile practices: they form plans, they set milestones, and they measure progress by how many teams they have engaged. Old habits die hard, but like most waterfall software projects, most waterfall-style Agile adoption efforts fail to produce the results desired. The problem is that to get the results they want, they have to ch...
With the introduction of IoT and Smart Living in every aspect of our lives, one question has become relevant: What are the security implications? To answer this, first we have to look and explore the security models of the technologies that IoT is founded upon. In his session at @ThingsExpo, Nevi Kaja, a Research Engineer at Ford Motor Company, discussed some of the security challenges of the IoT infrastructure and related how these aspects impact Smart Living. The material was delivered interac...
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
In 2014, Amazon announced a new form of compute called Lambda. We didn't know it at the time, but this represented a fundamental shift in what we expect from cloud computing. Now, all of the major cloud computing vendors want to take part in this disruptive technology. In his session at 20th Cloud Expo, Doug Vanderweide, an instructor at Linux Academy, discussed why major players like AWS, Microsoft Azure, IBM Bluemix, and Google Cloud Platform are all trying to sidestep VMs and containers wit...
The Internet giants are fully embracing AI. All the services they offer to their customers are aimed at drawing a map of the world with the data they get. The AIs from these companies are used to build disruptive approaches that cannot be used by established enterprises, which are threatened by these disruptions. However, most leaders underestimate the effect this will have on their businesses. In his session at 21st Cloud Expo, Rene Buest, Director Market Research & Technology Evangelism at Ara...
"We are a monitoring company. We work with Salesforce, BBC, and quite a few other big logos. We basically provide monitoring for them, structure for their cloud services and we fit into the DevOps world" explained David Gildeh, Co-founder and CEO of Outlyer, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
When growing capacity and power in the data center, the architectural trade-offs between server scale-up vs. scale-out continue to be debated. Both approaches are valid: scale-out adds multiple, smaller servers running in a distributed computing model, while scale-up adds fewer, more powerful servers that are capable of running larger workloads. It’s worth noting that there are additional, unique advantages that scale-up architectures offer. One big advantage is large memory and compute capacity...
SYS-CON Events announced today that IBM has been named “Diamond Sponsor” of SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California.